Uncategorised

The Lay Advisory Group of The Royal College of Ophthalmologists strongly criticises NHS England’s decision of 2 July 2015 to not routinely commission adalimumab and infliximab for adults and children with severe refractory uveitis. England is now the only country in the UK that denies access to anti TNF therapy for severe refractory uveitis in

• 7 August 2015

• Tags | adalimumab | lay advisory group | Severe Refractory Uveitis | uveitis

A unique one year fellowship opportunity is available commencing in Feb 2016.  Lions Outback Vision (based at the Lions Eye Institute in Perth) has provided oversight and coordination of outreach eye health services in Western Australia for 5 years. The fellowship post has delivered a higher level of continuity for communities in the northwest of

• 4 August 2015

The Health Technology Assesment unit (HTA) workstream commissions research proposals that address specific topics or themes, as identified by the HTA boards and panels. There are three rounds a year (opening March, July and October) containing up to 20 separate call topics. The following commissioning briefs are now available if you are interested in appying: Self-monitoring

• 27 July 2015

The Royal College of Ophthalmologists welcomes the Final Appraisal Determination (FAD) from NICE recommending EYLEA (aflibercept) as a treatment option for patients with visual impairment due to diabetic macular oedema (DMO) and a central retinal thickness of >400 micrometers. We hope that clinical commissioning groups will support the rapid implementation of the guidance so patients

• 22 July 2015

The Department of Health in England has commissioned the National Institute for Health and Care Excellence (NICE) to develop a guideline for the diagnosis and management of cataracts, with particular focus on the indications for cataract extraction and lens implant errors. Not only will the proposed guideline be of great significance to patients and ophthalmologists in England, but it is likely

• 22 July 2015